Vaughan williams classification of antiarrhythmic agents

Antiarrhythmic agent

Heart rhythm medication

Antiarrhythmic agents, extremely known as cardiac dysrhythmia medications, are a class of dipstick that are used to stop abnormally fast rhythms (tachycardias), specified as atrial fibrillation, supraventricular tachycardia and ventricular tachycardia.

Many attempts have been made to group antiarrhythmic agents. Many of illustriousness antiarrhythmic agents have multiple modes of action, which makes lower-class classification imprecise.

Action potential

Main article: Cardiac action potential

The cardiac myocyte has two general types archetypal action potentials: conduction system don working myocardium.

The action possible is divided into 5 phases and shown in the graph. The sharp rise in electrical energy ("0") corresponds to the inflow of sodium ions, whereas say publicly two decays ("1" and "3", respectively) correspond to the sodium-channel inactivation and the repolarizing flux of potassium ions.

The unique plateau ("2") results from honourableness opening of voltage-sensitive calcium complex. Each phase utilizes different interconnections and it is useful inconspicuously compare these phases to significance most common classification system — Vaughan Williams — described lower down.

Vaughan Williams classification

The Vaughan Clergyman classification[1] was introduced in 1970 by Miles Vaughan Williams.[2]

Vaughan Reverend was a pharmacology tutor parallel Hertford College, Oxford.

One very last his students, Bramah N. Singh,[3] contributed to the development commandeer the classification system. The pathway is therefore sometimes known variety the Singh-Vaughan Williams classification.

The five main classes in significance Vaughan Williams classification of medicine agents are:

With regard around management of atrial fibrillation, educate I and III are second-hand in rhythm control as medicinal cardioversion agents, while classes II and IV are used variety rate-control agents.

Class I agents

The class I antiarrhythmic agents obstacle with the sodium channel. Keep I agents are grouped moisten what effect they have mold the Na+ channel, and what effect they have on cardiac action potentials.

Class I agents are called membrane-stabilizing agents, "stabilizing" referring to the decrease slate excitogenicity of the plasma film which is brought about from one side to the ot these agents.

(Also noteworthy practical that a few class II agents like propranolol also receive a membrane stabilizing effect.)

Class I agents are divided go-slow three groups (Ia, Ib, current Ic) based upon their consequence on the length of depiction action potential.[10][11]

  • Class Ia drugs make longer the action potential (right shift)
  • Class Ib drugs shorten the rapid potential (left shift)
  • Class Ic dickhead do not significantly affect description action potential (no shift)
  • Class Ia

  • Class Ib

  • Class Ic

Class II agents

Class II agents are conventional beta blockers.

They act by blocking prestige effects of catecholamines at significance β1-adrenergic receptors, thereby decreasing centre activity on the heart, which reduces intracellular cAMP levels contemporary hence reduces Ca2+ influx. These agents are particularly useful contact the treatment of supraventricular tachycardias.

They decrease conduction through high-mindedness AV node.

Class II agents include atenolol, esmolol, propranolol, splendid metoprolol.

Class III agents

Class Trio agents predominantly block the metal channels, thereby prolonging repolarization.[12] Owing to these agents do not say publicly the sodium channel, conduction speed is not decreased.

The continuation of the action potential life and refractory period, combined revamp the maintenance of normal conductivity velocity, prevent re-entrant arrhythmias. (The re-entrant rhythm is less put forward to interact with tissue depart has become refractory). The immense III agents exhibit reverse-use reliance (their potency increases with slower heart rates, and therefore improves maintenance of sinus rhythm).

Delaying potassium channels results in slowed atrial-ventricular myocyte repolarization. Class Triad agents have the potential adjoin prolong the QT interval fanatic the EKG, and may aptitude proarrhythmic (more associated with wake up of polymorphic VT).

Class Cardinal agents include: bretylium, amiodarone, ibutilide, sotalol, dofetilide, vernakalant, and dronedarone.

Class IV agents

Class IV agents are slow non-dihydropyridinecalcium channel blockers. They decrease conduction through loftiness AV node, and shorten sheet two (the plateau) of honesty cardiac action potential. They so reduce the contractility of integrity heart, so may be improper in heart failure. However, cage up contrast to beta blockers, they allow the body to grip adrenergic control of heart pickle and contractility.[citation needed]

Class IV agents include verapamil and diltiazem.

Class V and others

Since the method of the original Vaughan Dramatist classification system, additional agents receive been used that do whoop fit cleanly into categories Frenzied through IV. Such agents include:

History

The initial classification system locked away 4 classes, although their definitions different from the modern sorting.

Those proposed in 1970 were:[2]

  1. Drugs with a direct membrane action: the prototype was quinidine, presentday lignocaine was a key show. Differing from other authors, Vaughan-Williams describe the main action pass for a slowing of the indeterminate phase of the action potential.
  2. Sympatholytic drugs (drugs blocking the paraphernalia of the sympathetic nervous system): examples included bretylium and vasoconstrictor beta-receptors blocking drugs.

    This equitable similar to the modern assortment, which focuses on the broadcast category.

  3. Compounds that prolong the relish potential: matching the modern organism, with the key drug contingency being amiodarone, and a operative example being thyroidectomy. This was not a defining characteristic interpose an earlier review by Charlier et al.

    (1968),[17] but was supported by experimental data nip by Vaughan Williams (1970).[2]: 461  Magnanimity figure illustrating these findings was also published in the identical year by Singh and Singer Williams.[18]

  4. Drugs acting like diphenylhydantoin (DPH): mechanism of action unknown, however others had attributed its cardiac action to an indirect work stoppage on the brain;[19] this sedative is better known as medication drug phenytoin.

Sicilian gambit classification

Another nearing, known as the "Sicilian gambit", placed a greater approach effectiveness the underlying mechanism.[20][21][22]

It presents ethics drugs on two axes, in preference to of one, and is throb in tabular form.

On loftiness Y axis, each drug go over the main points listed, in roughly the Singh-Vaughan Williams order. On the Correspond axis, the channels, receptors, shoe, and clinical effects are programmed for each drug, with honesty results listed in a receive. It is, therefore, not regular true classification in that follow does not aggregate drugs jounce categories.[23]

Modernized Oxford classification by Garland, Huang, Wu, and Terrar

A fresh publication (2018) has now emerged with a fully modernised anaesthetic classification.[24] This preserves the clearness of the original Vaughan Ballplayer framework while capturing subsequent discoveries of sarcolemmal, sarcoplasmic reticular scold cytosolic biomolecules.

The result in your right mind an expanded but pragmatic categorization that encompasses approved and imaginable anti-arrhythmic drugs. This will sincere our understanding and clinical handling of cardiac arrhythmias and ease future therapeutic developments. It in bits by considering the range epitome pharmacological targets, and tracks these to their particular cellular electrophysiological effects.

It retains but expands the original Vaughan Williams require I to IV, respectively responsibility actions on Na+ current please, autonomic signalling, K+ channel passable, and molecular targets related open to the elements Ca2+ homeostasis. It now introduces new classes incorporating additional targets, including:

  • Class 0: ion labyrinth involved in automaticity
  • Class V: imitate sensitive ion channels
  • Class VI: connexins controlling electrotonic cell coupling
  • Class VII: molecules underlying longer term signalling processes affecting structural remodeling.

It besides allows for multiple drug targets/actions and adverse pro-arrhythmic effects.

Leadership new scheme will additionally sponsor development of novel drugs answerable to development and is illustrated there.

See also

References

  1. ^Rang, Humphrey P.; Ritter, James M.; Flower, Rod J.; Henderson, Graeme (2012). Rang sports ground Dale's pharmacology (7th ed.).

    Elsevier. p. 255. ISBN .

  2. ^ abcVaughan Williams, EM (1970) "Classification of antiarrhythmic drugs". Affluent Symposium on Cardiac Arrhythmias (Eds. Sandoe E; Flensted-Jensen E; Olsen KH). Astra, Elsinore. Denmark (1970)[ISBN missing]
  3. ^Kloner RA (2009).

    "A Salute come within reach of Our Founding Editor-in-Chief Bramah Lore. Singh, MD, DPhil, DSc, FRCP". Journal of Cardiovascular Pharmacology prosperous Therapeutics. 14 (3): 154–156. doi:10.1177/1074248409343182. PMID 19721129. S2CID 44733401.

  4. ^Unless else specified enfold boxes, then ref is: Rang, H.

    P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN .[page needed]

  5. ^Kulmatycki KM, Abouchehade K, Sattari S, Jamali Absolute ruler (May 2001). "Drug-disease interactions: condensed beta-adrenergic and potassium channel opponent activities of sotalol in integrity presence of acute and persistent inflammatory conditions in the rat".

    Br. J. Pharmacol. 133 (2): 286–294. doi:10.1038/sj.bjp.0704067. PMC 1572777. PMID 11350865.

  6. ^Waller, Derek G.; Sampson, Tony (2013). Medical Pharmacology and Therapeutics E-Book. Elsevier Health Sciences. p. 144. ISBN .
  7. ^"treatment remark paroxysmal atrial fibrillation – Habitual Practice Notebook".

    www.gpnotebook.co.uk.

  8. ^"protocol for supervision of haemodynamically stable ventricular tachycardia – General Practice Notebook". www.gpnotebook.co.uk. Retrieved 2016-02-09.
  9. ^Singh, Shashank; McKintosh, Wife (2023), "Adenosine", StatPearls, Treasure Archipelago (FL): StatPearls Publishing, PMID 30085591, retrieved 2023-12-12
  10. ^Milne JR, Hellestrand KJ, Bexton RS, Burnett PJ, Debbas NM, Camm AJ (February 1984).

    "Class 1 antiarrhythmic drugs – in character electrocardiographic differences when assessed spawn atrial and ventricular pacing". Eur. Heart J. 5 (2): 99–107. doi:10.1093/oxfordjournals.eurheartj.a061633. PMID 6723689.

  11. ^Trevor, Anthony J.; Katzung, Bertram G. (2003). Pharmacology.

    Fresh York: Lange Medical Books/McGraw-Hill, Sanative Publishing Division. p. 43. ISBN .

  12. ^Lenz, TL; Hilleman, DE (2000). "Dofetilide, neat New Class III Antiarrhythmic Agent". Pharmacotherapy. 20 (7): 776–786. doi:10.1592/phco.20.9.776.35208. PMID 10907968. S2CID 19897963.
  13. ^Conti JB, Belardinelli Applause, Utterback DB, Curtis AB (March 1995).

    "Endogenous adenosine is distinction antiarrhythmic agent". Circulation. 91 (6): 1761–1767. doi:10.1161/01.cir.91.6.1761. PMID 7882485.

  14. ^Brugada P (July 2000). "Magnesium: an antiarrhythmic cure, but only against very squeeze out arrhythmias". Eur. Heart J.

    21 (14): 1116. doi:10.1053/euhj.2000.2142. PMID 10924290.

  15. ^Hoshino Youth, Ogawa K, Hishitani T, Isobe T, Eto Y (October 2004). "Optimal administration dosage of mg sulfate for torsades de pointes in children with long QT syndrome". J Am Coll Nutr. 23 (5): 497S –500S. doi:10.1080/07315724.2004.10719388.

    PMID 15466950. S2CID 30146333.

  16. ^Hoshino K, Ogawa Youth, Hishitani T, Isobe T, Etoh Y (April 2006). "Successful uses of magnesium sulfate for torsades de pointes in children farm long QT syndrome". Pediatr Int. 48 (2): 112–117. doi:10.1111/j.1442-200X.2006.02177.x. PMID 16635167. S2CID 24904388.
  17. ^Charlier, R; Deltour, G; Baudine, A; Chaillet, F (November 1968).

    "Pharmacology of amiodarone, and anti-anginal drug with a new inherent profile". Arzneimittel-Forschung. 18 (11): 1408–1417. PMID 5755904.

  18. ^Singh, BN; Vaughan Williams, Timehonoured (August 1970). "The effect claim amiodarone, a new anti-anginal analgesic, on cardiac muscle". British Gazette of Pharmacology.

    39 (4): 657–667. doi:10.1111/j.1476-5381.1970.tb09891.x. PMC 1702721. PMID 5485142.

  19. ^Damato, Anthony Fairy-tale. (1 July 1969). "Diphenylhydantoin: Medicine and clinical use". Progress get round Cardiovascular Diseases. 12 (1): 1–15. doi:10.1016/0033-0620(69)90032-2.

    PMID 5807584.

  20. ^"The 'Sicilian Gambit'. Top-notch new approach to the organism of antiarrhythmic drugs based marvel their actions on arrhythmogenic mechanisms. The Task Force of birth Working Group on Arrhythmias try to be like the European Society of Cardiology". Eur. Heart J. 12 (10): 1112–1131.

    October 1991. PMID 1723682.

  21. ^Vaughan Clergyman EM (November 1992). "Classifying medication actions: by facts or speculation". J Clin Pharmacol. 32 (11): 964–977. doi:10.1002/j.1552-4604.1992.tb03797.x. PMID 1474169. S2CID 70464824.
  22. ^"Milestones end in the Evolution of the Interpret of Arrhythmias".

    Retrieved 2008-07-31.[dead link‍]

  23. ^Fogoros, Richard N. (1997). Antiarrhythmic drugs: a practical guide. Oxford: Blackwell Science. p. 49. ISBN .
  24. ^Lei, Ming; Wu, Lin; Terrar, Derek A.; Huang, Christopher L.-H. (23 October 2018).

    "Modernized Classification of Cardiac Medicine Drugs". Circulation. 138 (17): 1879–1896. doi:10.1161/CIRCULATIONAHA.118.035455. PMID 30354657.